Comprehensive Analysis of the Factors that Drive and Restrict Pneumonia Vaccine Market Growth by 2023

Pneumonia is a lung infection that occurs in one or both lungs caused by bacteria, viruses or fungi. However, bacterial pneumonia is the most common form in adults.

Pneumonia causes inflammation in the air bladders of the lungs (also called alveoli), causing the alveoli to become filled with liquids (pus cells), causing breathing problems. Pneumococcal disease is common in young children, but the elderly are at greatest risk of serious pneumococcal infection and even death.

Get Access to TOC / Sample Report @
https://www.alliedmarketresearch.com/request-toc-and-sample/2730?utm_source=openpr_ss

Therefore, the Centers for Disease Control and Prevention (CDC) recommends the administration of two pneumococcal vaccines, PCV13, and PPSV23. The main factors driving the growth of the global pneumococcal vaccine market are increased pneumonia worldwide, increased government interest in pneumococcal vaccination programs, and the introduction of new pneumococcal vaccines such as PCV10.

However, the time it takes to produce pneumococcal vaccines is long and the high costs associated with the development of such vaccines inhibit market growth. The development of a protein-based combination pneumococcal vaccine is expected to provide an advantageous opportunity for expanding this market.

The global pneumococcal vaccine market is categorized by type, application and geography. Depending on the type, the market is divided into pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). The applications covered in this study include pneumonia, meningitis and sepsis. Geographically markets are analyzed in North America, Europe, Asia Pacific and LAMEA.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2730?utm_source=openpr_ss

Market Players:

• Pfizer Inc.
• GlaxoSmithKline Plc.
• Merck & Co. Inc.
• Sanofi Pasteur
• Serum Institute of India Pvt. Ltd.
• Johnson & Johnson
• Astellas Pharma Inc.

Key Benefits of Pneumonia Vaccine Market Report:

• This study provides an in-depth analysis of the global pneumococcal vaccine market with current trends and future estimates to identify impending investment pockets.
• A comprehensive analysis of factors driving and limiting market growth is provided in the report.
• A comprehensive quantitative analysis of the industry is provided during 2016-2023 to enable stakeholders to take advantage of dominant market opportunities.
• A comprehensive analysis of the major sectors of the industry will help you understand trends in pneumococcal vaccine types around the world.

Browse More Information of Report @ https://www.alliedmarketresearch.com/pneumonia-vaccine-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.